John S. Kovach, MD Professor Office Phone: (631) 444-9339 e-mail: john.kovach@stonybrook.edu Academic Interests: Cancer; Molecular Biomarkers of Cancer; Molecular Epidemiology; Environmental Exposures |
Blaszyk H, Hartmann A, Cunningham J, Schaid D, Wold LE, Kovach JS, Sommer SS. A prospective trial of mid-western breast cancer patients. A p53 gene mutation is the most important predictor of adverse outcome. Int. J. Cancer.2000; 89:32-38.
Buzin CH, Tang S-H-E, Cunningham JM, Shibata A, Ross RK, Hartman A, Blaszyk H, Kovach JS. Low frequency of p53 gene mutations in breast cancers of Japanese-American women. Nutrition and Cancer. 2001; 39:72-77.
Zhu W, Wang X, Ma Y, Rao M, Glimm J, Kovach, JS. Detection of Cancer Specific Markers Amid Massive Mass Spectral Data. Proc. Natl. Acad. Sci. (USA). 2003;100: 14666-14671.
Kenning GG, Rodriguez R, Zotev VS, Moslemi A, Wilson S, Hawel L, Byus C, Kovach JS. Detection of magnetically enhanced cancer tumors using SQUID magnetometry: A feasibility study. Review of Scientific Instruments. 2005; 76: 014303-1 to 9.
Schoenfeld ER, Davis MV, Kovach JS, Mchunguzi C, Nies MA. A community and Academic Partnership to Improve Breast Cancer Outcomes for African Americans on Long island: a Ministry if Health Dissemination. Home Health Care Management and Practice.2006; 18:361-369.
Gallagher CN, Kovach JS, Meliker JR. Urinary Cadmium and Osteoporosis in US Women = > 50 Years of Age: NHANES 1988-1994 and 1999-2004. 2008 Env Health Perspect. 116 (10).
Gallagher CM, Moonga BS, Kovach JS. Cadmium, follicle-stimulating hormone, and effects on bone in women age 42-60 years, NHANES III. Environ Res. 2010 Jan;110(1):105-11. Epub.
Gallagher CM, Chen JJ, Kovach JS. Urine cadmium and breast cancer: NHANES 1999-2008 and Long Island, New York, 2008-2009 Submitted, July 2010